About Abyntek
Abyntek is a company based in Derio (Spain) founded in 2006. It operates as a B2B and Distribution. Abyntek offers products and services including Antibodies, Proteins, Kits, and Custom Services. Abyntek operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and BBI Solutions, among others.
- Headquarter Derio, Spain
- SectorsHealthcare
- Phone•••• ••••
- Website abyntek.com
- Social X Facebook
- Legal Name Abyntek Biopharma S.L.
Products & Services of Abyntek
Abyntek offers a comprehensive portfolio of products and services, including Antibodies, Proteins, Kits, and Custom Services.
Specialized proteins used for research and diagnostic applications.
Recombinant proteins for scientific and biological assays.
ELISA kits for detecting biological markers in samples.
Tailored services for bioreagent development and procurement.
Competitors of Abyntek
Abyntek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Teknova, Meridian Bioscience and BBI Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| bbisolutions.com | 1986 | Crumlin, United Kingdom | – | 301 | Kits and reagents are developed for life science research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| biochain.com | 1994 | Hayward, United States | $7.34M | 24 | Provider of products and services for clinical diagnosis, genomics, and proteomics | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| biolamina.com | 2008 | Sundbyberg, Sweden | $18.25M | – | Recombinant laminins are produced for stem cell culture matrices. |
Detailed competitors of Abyntek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Abyntek
The website of Abyntek (abyntek.com) receives about 34.5K visits a month.
- Monthly visits34.5K
▲ 21.2% vs previous month
Websites whose visitors overlap most with Abyntek. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bio-connect.nl | 86% | 27.1K | #1,078,126 | View details | |
| peakproteins.com | 82% | 10.7K | #2,177,546 | View details | |
| moleculardevices.com | 80% | 131.7K | #329,224 | View details | |
| sebbm.es | 78% | 57.2K | #650,152 | View details | |
| neogen.com | 76% | 177.9K | #243,259 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Abyntek
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Abyntek
10 companies that operate in the same segment as Abyntek (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Abyntek
Abyntek was founded in 2006.
Abyntek is headquartered in Derio, Spain. It is registered at Derio, Pais Vasco, Spain.
Abyntek Biopharma is a leading Spanish company supplying bioreactivos, with expertise in antibodies and recombinant proteins. They offer products, custom services, and brand representation, assisting researchers through technical advice and efficient procurement. Based in Zamudio, Vizcaya, they serve academic and research institutions with reliable solutions for biological assays and diagnostics.
Abyntek's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Abyntek offers Antibodies, Proteins, Kits, and Custom Services.
Abyntek operates through Abyntek Biopharma S.L..